Petros Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of PTPI for the last quarter is 1.67 M USD, and it's 16.02% lower compared to the previous quarter. The net income of Q3 23 is -4.55 M USD.